12/19/2024
3:10 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
6:06 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:18 AM | Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2024
6:22 AM | Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:10 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/07/2024
8:56 AM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
11/05/2024
8:00 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
8:06 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
7:30 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:05 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
10:50 AM | Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
3:44 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
10:37 AM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
4:00 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
4:51 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:52 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:49 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:51 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:15 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:14 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:42 PM | Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:42 PM | Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:45 PM | Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:47 PM | Beam Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:47 PM | Beam Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:48 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:09 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:19 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
3:25 PM | Beam Therapeutics (Filer)
| Form ARS | |
04/19/2024
3:15 PM | Beam Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024
3:20 PM | Beam Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:55 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
04/03/2024
6:39 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:40 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:43 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:33 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:36 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:22 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:13 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:40 AM | Beam Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:22 AM | Beam Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
5:43 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
1:34 PM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Beam Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
2:38 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Beam Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
6:27 AM | Beam Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/31/2024
3:47 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
3:59 PM | Beam Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
7:42 AM | Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/08/2024
5:55 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:30 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
9:56 AM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free BEAM Stock Alerts